The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.
Saved in:
| Title: | The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study. |
|---|---|
| Authors: | Herrington, William G (AUTHOR), Preiss, David (AUTHOR), Haynes, Richard (AUTHOR), Eynatten, Maximilian von (AUTHOR), Staplin, Natalie (AUTHOR), Hauske, Sibylle J (AUTHOR), George, Jyothis T (AUTHOR), Green, Jennifer B (AUTHOR), Landray, Martin J (AUTHOR), Baigent, Colin (AUTHOR), Wanner, Christoph (AUTHOR) |
| Source: | Clinical Kidney Journal. Aug2020, Vol. 13 Issue 4, p722-722. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
